Literature DB >> 10744642

In vivo cell penetration and intracellular transport of anti-Sm and anti-La autoantibodies.

S X Deng1, E Hanson, I Sanz.   

Abstract

Anti-nuclear autoantibodies (ANA) are the hallmark of systemic autoimmune diseases. Yet, the in vivo function of ANA remains controversial to a large extent due to the intracellular nature of their antigenic targets. It has been reported that a subset of autoantibodies can penetrate live cells and translocate into the subcellular compartments containing the corresponding antigens. The studies presented herein show that murine anti-Sm and anti-La monoclonal autoantibodies can also enter a variety of cell types from different animal species and that the cell penetration activity is not isotype-restricted. Interestingly, only mAb with cross-reactivity against double-stranded DNA did enter cells. Both these autoantibodies rapidly accumulate in the nucleus of viable cells but display different penetration kinetics. In co-localization experiments, monoclonal autoantibodies did not accumulate significantly within endocytic vesicles containing dextran, suggesting that they are internalized by mechanisms distinct from conventional receptor-mediated endocytosis. This report represents the first evidence that anti-La and anti-Sm autoantibodies are capable of entering live cells. Our observations support the notion that the phenomenon of intracellular autoantibodies may have a larger scope than previously reported and are consistent with a potential pathogenic role for ANA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744642     DOI: 10.1093/intimm/12.4.415

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  10 in total

1.  The La antigen associates with the human telomerase ribonucleoprotein and influences telomere length in vivo.

Authors:  L P Ford; J W Shay; W E Wright
Journal:  RNA       Date:  2001-08       Impact factor: 4.942

2.  Passive transfer of antibodies to the linear epitope 60 kD Ro 273-289 induces features of Sjögren's syndrome in naive mice.

Authors:  J S Maier-Moore; B T Kurien; A D'Souza; L Bockus; S Asfa; Y Dorri; S Hubbell; O Yeliosof; D Obeso; T R Schoeb; R Jonsson; R H Scofield
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

3.  Anti-Interferon-Inducible Protein 16 Antibodies Associate With Digital Gangrene in Patients With Scleroderma.

Authors:  Zsuzsanna H McMahan; Ami A Shah; Dhananjay Vaidya; Fredrick M Wigley; Antony Rosen; Livia Casciola-Rosen
Journal:  Arthritis Rheumatol       Date:  2016-05       Impact factor: 10.995

4.  A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen.

Authors:  Dahai Xue; Hong Shi; James D Smith; Xinguo Chen; Dennis A Noe; Tommy Cedervall; Derek D Yang; Elizabeth Eynon; Douglas E Brash; Michael Kashgarian; Richard A Flavell; Sandra L Wolin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-03       Impact factor: 11.205

5.  DNA-histone complexes as ligands amplify cell penetration and nuclear targeting of anti-DNA antibodies via energy-independent mechanisms.

Authors:  Markella Zannikou; Sofia Bellou; Petros Eliades; Aikaterini Hatzioannou; Michael D Mantzaris; George Carayanniotis; Stratis Avrameas; Peggy Lymberi
Journal:  Immunology       Date:  2015-11-24       Impact factor: 7.397

Review 6.  The Ro 60 kDa autoantigen: insights into cellular function and role in autoimmunity.

Authors:  Xinguo Chen; Sandra L Wolin
Journal:  J Mol Med (Berl)       Date:  2004-04       Impact factor: 4.599

Review 7.  Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review.

Authors:  Renske G Kamperman; Anneke J van der Kooi; Marianne de Visser; Eleonora Aronica; Joost Raaphorst
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

8.  Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products.

Authors:  Zhiqun Zhang; J Susie Zoltewicz; Stefania Mondello; Kimberly J Newsom; Zhihui Yang; Boxuan Yang; Firas Kobeissy; Joy Guingab; Olena Glushakova; Steven Robicsek; Shelley Heaton; Andras Buki; Julia Hannay; Mark S Gold; Richard Rubenstein; Xi-Chun May Lu; Jitendra R Dave; Kara Schmid; Frank Tortella; Claudia S Robertson; Kevin K W Wang
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

Review 9.  Resveratrol Role in Autoimmune Disease-A Mini-Review.

Authors:  Ana Lígia de Brito Oliveira; Valter Vinicius Silva Monteiro; Kely Campos Navegantes-Lima; Jordano Ferreira Reis; Rafaelli de Souza Gomes; Dávila Valentina Silva Rodrigues; Silvia Letícia de França Gaspar; Marta Chagas Monteiro
Journal:  Nutrients       Date:  2017-12-01       Impact factor: 5.717

10.  Rituximab in the Treatment of Interstitial Lung Diseases Related to Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis: A Systematic Review.

Authors:  Chenjia He; Wenyu Li; Qibing Xie; Geng Yin
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.